The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(+)-1,8-dimethyl-5-morpholino-8a-phenyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-3a-ol ID: ALA4752827
PubChem CID: 162653305
Max Phase: Preclinical
Molecular Formula: C22H27N3O2
Molecular Weight: 365.48
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CN1CC[C@@]2(O)c3cc(N4CCOCC4)ccc3N(C)[C@@]12c1ccccc1
Standard InChI: InChI=1S/C22H27N3O2/c1-23-11-10-21(26)19-16-18(25-12-14-27-15-13-25)8-9-20(19)24(2)22(21,23)17-6-4-3-5-7-17/h3-9,16,26H,10-15H2,1-2H3/t21-,22-/m1/s1
Standard InChI Key: DBWPOSGITJRQNX-FGZHOGPDSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
8.4443 -25.5155 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9321 -24.8526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4509 -24.1850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6642 -25.2590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6724 -24.4422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8846 -25.5023 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4136 -24.8359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8989 -24.1843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5806 -23.4382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7732 -23.3425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2851 -23.9990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6101 -24.7425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6643 -23.6201 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6560 -26.0800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9381 -26.4794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9296 -27.2996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6375 -27.7200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3555 -27.3102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3606 -26.4914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6243 -26.2810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6930 -26.2939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4499 -22.5920 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9383 -21.9368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6383 -22.4967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3151 -21.7462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8034 -21.0909 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6150 -21.1862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 1 1 0
1 2 1 0
2 3 1 0
3 5 1 0
4 5 1 0
5 8 1 0
7 6 1 0
6 4 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
5 13 1 1
4 14 1 1
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
6 20 1 0
1 21 1 0
10 22 1 0
22 23 1 0
22 24 1 0
24 25 1 0
23 27 1 0
25 26 1 0
26 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 365.48Molecular Weight (Monoisotopic): 365.2103AlogP: 2.35#Rotatable Bonds: 2Polar Surface Area: 39.18Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.84CX Basic pKa: 6.98CX LogP: 3.21CX LogD: 3.07Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.88Np Likeness Score: -0.09
References 1. Blom AEM,Su JY,Repka LM,Reisman SE,Dougherty DA. (2020) Synthesis and Biological Evaluation of Pyrroloindolines as Positive Allosteric Modulators of the α1β2γ2 GABA Receptor., 11 (11): [PMID:33214830 ] [10.1021/acsmedchemlett.0c00340 ]